β-lactamases:: which ones are clinically important?

被引:52
作者
Rice, LB
Bonomo, RA
机构
[1] VA Med Ctr, Med Serv 111W, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA
关键词
D O I
10.1054/drup.2000.0144
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The introduction of a large array of beta-lactam antibiotics has spawned the emergence of an even larger variety of beta-lactamases designed to confer resistance to these agents. beta-lactamases are produced by both gram-positive and gram-negative bacteria, but their clinical importance is far greater among the gram-negatives. The virtual explosion in our knowledge about the variety of these enzymes can often create confusion and frustration among those not well versed in the field. In this paper, we attempt to focus the discussion of beta-lactamases on those enzymes that are of the greatest clinical importance, the Ambler Class A and C enzymes. We also discuss the growing importance of the Ambler Class B metallo beta-lactamases, which hydrolyze carbapenems and are increasing in prevalence in areas of significant carbapenem usage. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:178 / 189
页数:12
相关论文
共 91 条